Jennifer Evans Stacey

General Counsel, AUXILIUM PHARMACEUTICALS INC.

Companies

NeoGenGeneral counsel Apr 13, 2026 to now¹
Context Therapeutics Inc.Board member Oct 19, 2021 to now²
Galera Therapeutics, Inc.Officer Oct 12, 2021 to Feb 28, 2023³
ANTARES PHARMA, INC.General counsel May 30, 2014 to Jun 1, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NeoGen NEOG38,627 shares⁵$450.6K at $11.66Aug 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 14, 2026Granted 38,627 shares at $11.65 of NeoGen⁵
May 1, 2026Granted 39,349 shares at $9.53 of NeoGen⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeoGen, General counsel
2
SEC EDGARContext Therapeutics Inc., Board member
3
SEC EDGARGalera Therapeutics, Inc., Officer
4
SEC EDGARANTARES PHARMA, INC., General counsel
5
SEC EDGARNeoGen shares after the filing of Aug 14, 2026
6
SEC EDGARForm 4 filed May 4, 2026